Verrica Pharmaceuticals’ YCANTH Receives New Chemical Entity Status, Orange Book Listing From FDA
The Dermatology Digest
MARCH 26, 2024
Verrica Pharmaceuticals Inc.’s The post Verrica Pharmaceuticals’ YCANTH Receives New Chemical Entity Status, Orange Book Listing From FDA appeared first on The Dermatology Digest. s YCANTH now has New Chemical Entity (NCE) Status and a listing in the Orange Book from the U.S. YCANTH (cantharidin) topical solution, 0.7%
Let's personalize your content